Nelson Jeffrey Edward 4
4 · Milestone Pharmaceuticals Inc. · Filed Feb 4, 2026
Research Summary
AI-generated summary of this filing
Milestone (MIST) COO Nelson Receives 340,000-Share Awards
What Happened
Nelson Jeffrey Edward (COO) received two derivative awards from Milestone Pharmaceuticals on February 2, 2026: a grant of 204,000 option-type shares and 136,000 restricted stock units (RSUs), for a total of 340,000 shares. Both awards were reported as acquired at $0.00 per share (standard for equity grants); these are compensation awards, not open-market purchases or sales.
Key Details
- Transaction date: 2026-02-02; Filing date: 2026-02-04 (timely).
- Awards: 204,000 (derivative option-style award) and 136,000 RSUs; combined 340,000 shares; acquisition price reported $0.00.
- Vesting for the 204,000-option award: 1/4 vest on Feb 2, 2027, then 1/36 of the remainder each month thereafter, subject to continued service (Footnote F1).
- RSU details: each RSU converts to one common share (Footnote F2). RSU vesting: 1/4 on each of Feb 2, 2027, 2028, 2029 and 2030 (Footnote F3).
- Shares owned after the transaction: not specified in the filing.
- Filing legend/codes: Transaction code A = Award/Grant; these are derivative grants, not immediate sales or purchases.
Context
These awards are typical executive compensation meant to retain and incentivize management — they vest over multiple years and do not represent immediate cash proceeds or an open-market purchase. For retail investors, note that such grants become economically meaningful only as they vest and, for options, if exercised; they do not necessarily indicate a near-term insider buy or sell.
Insider Transaction Report
- Award
Employee Stock Option (right to buy)
[F1]2026-02-02+204,000→ 204,000 totalExercise: $1.97Exp: 2036-02-02→ Common Shares (204,000 underlying) - Award
Restricted Stock Unit
[F2][F3]2026-02-02+136,000→ 136,000 total→ Common Shares (136,000 underlying)
Footnotes (3)
- [F1]One-fourth (1/4th) of the shares subject to the option vest on February 2, 2027, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
- [F2]Each restricted stock unit represents a contingent right to receive one common share.
- [F3]One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of February 2, 2027, February 2, 2028, February 2, 2029 and February 2, 2030, subject to the Reporting Person continuing to provide service through each such date.